BA
ACH

Bivin & Associates’s Accendra Health ACH Stock Holding History

Bivin & Associates’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$1K Sell
18
-2
-10% -$72 ﹤0.01% 288
2022
Q1 		$1K Hold
20
– – ﹤0.01% 315
2021
Q4 		$1K Buy
+20
New +$784 ﹤0.01% 347

Other funds holding ACH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bivin & Associates's ACH Position: Q2 2022 in Review

Bivin & Associates reduced its Accendra Health (ACH) stake by 10% in Q2 2022, selling an estimated $72 and leaving 18 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #288.

Bivin & Associates first reported a position in ACH in Q4 2021 and has held it in 3 quarters since. 251 funds tracked by Wall St. Rank hold ACH as of Q2 2022.

  • Bivin & Associates held 18 shares of Accendra Health worth $1K as of Q2 2022.
  • Bivin & Associates sold 2 Accendra Health shares in Q2 2022, an estimated $72.
  • Accendra Health made up ﹤0.01% of Bivin & Associates's portfolio in Q2 2022, its #288 holding.
  • Bivin & Associates first reported a position in Accendra Health in Q4 2021 and has held it in 3 quarters since.
  • 251 funds tracked by Wall St. Rank held Accendra Health as of Q2 2022.

Based on Bivin & Associates's 13F filing for Q2 2022, filed 11 Aug 2022.